Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, Gervais R, Ottensmeier C, Szczesna A, Kazarnowicz A, Beck JT, Westeel V, Felip E, Debieuvre D, Madroszyk A, Adam J, Lacoste G, Tavernaro A, Bastien B, Halluard C, Palanché T, Limacher JM. TG4010 immunotherapy and first -line chemotherapy for advanced non- small- cell lung cancer (TIME): results from the phase 2b part of a randomised, double -blind, placebo- controlled, phase 2b/3 trial. Lancet Oncol. 2016 Feb;17(2):212- 23. doi: 10.1016/S1470- 2045(15)00483- 0. Epub 2015 Dec 23.